Cytyc Awarded Sole Source Contract For The ThinPrep Pap Test By The U.S. Department Of Defense

Cytyc Corporation (Nasdaq:CYTC) today announced that it has won a sole source contract from the United States Department of Defense ("DOD") to provide the ThinPrep(R) Pap Test as the platform for cervical cancer screening at armed forces cervical cancer screening centers worldwide. The DOD negotiates contracts on behalf of the U.S. Army, Navy, Marines and Airforce. The new contract period commenced on October 1, covering the next governmental fiscal year and includes four (4) one-year option periods.